Endra Life Sciences
NDRA----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Endra Life Sciences(NDRA) predict that the EBIT is -2.174 M (-47.95%), Miss estimate;the EPS is -1.09 (+41.4%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.00B47.95%
-0.00B8.90%
-0.00B39.05%
EPSExceed expectations
-1.0941.40%
-1.2333.87%
+0.14007.53%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf